Global Duchenne Muscular Dystrophy Drugs Market Set to Reach $ 5.5 Billion by 2032, With a CAGR of 10.17% Driven by New Product Approvals, Launches, and a Favorable Landscape
29. April 2024 09:45 ET
|
Research and Markets
Dublin, April 29, 2024 (GLOBE NEWSWIRE) -- The "Global Duchenne Muscular Dystrophy Drugs Market by Product Type, Therapeutic Approach, End User, and Region 2024-2032" report has been added to ...
Global $111+ Billion Duchenne Muscular Dystrophy (DMD) Drugs Market Analysis 2024-2034 - Rapid Growth in Exon-Skipping Therapies Reflects Precision Medical Interventions Fueled by R&D
11. März 2024 14:03 ET
|
Research and Markets
Dublin, March 11, 2024 (GLOBE NEWSWIRE) -- The "Global Duchenne Muscular Dystrophy Drugs Market by Drug Type, by Distribution Channel, and By Region" report has been added to ...
Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho, FibroGen, Sarepta, Capricor, Daiichi Sankyo, Solid Biosciences
27. September 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy Market to Propel at a Significant CAGR by 2032, Assesses DelveInsight | Key Companies - Pfizer, Santhera, Taiho,...
Global Duchenne Muscular Dystrophy Drugs Business Report 2023: Market to Reach $18.1 Billion by 2030, Growing at a Staggering CAGR of 42.5%
26. Januar 2023 11:03 ET
|
Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Duchenne...
Duchenne Muscular Dystrophy (DMD) Clinical Trial Analysis Featuring 60+ Companies | DelveInsight
07. September 2022 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Duchenne Muscular Dystrophy (DMD) Clinical Trial Analysis Featuring 60+ Companies | DelveInsight Duchenne Muscular Dystrophy pipeline constitutes...
Duchenne Muscular Dystrophy Worldwide Outlook to 2030: Upcoming Strategies Include Gene Therapy and Cell Therapy
03. November 2021 05:23 ET
|
Research and Markets
Dublin, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering. Key...